Clinical trials
Neoplasm Recurrence, Local trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| CHU de Quebec-Universite Laval | 1 |
| Danish Breast Cancer Cooperative Group | 1 |
| Indiana University | 1 |
| Paracelsus Medical University | 1 |
| Peking University First Hospital | 1 |
| Portuguese Oncology Institute, Coimbra | 1 |
| Radboud University Medical Center | 1 |
| University Hospital, Montpellier | 1 |
| Universitätsmedizin Mannheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Recurrence, Local | 12 |
| Breast Neoplasms | 3 |
| Colonic Polyps | 2 |
| Neoplasm Metastasis | 2 |
| Pain | 2 |
| Recurrence | 2 |
| Adenoma | 1 |
| Agnosia | 1 |
| Breast Diseases | 1 |
| Cicatrix | 1 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.